Molecular Imaging: Page 25

Amsterdam team evaluates Alzheimer's disease biomarkers
By Will Morton
A plasma tau biomarker and tau PET imaging performed equally well at identifying Alzheimer's disease pathology, yet tau PET appears superior for monitoring disease staging and clinical progression, according to Dutch investigators.
October 20, 2022
2022 10 20 23 15 3577 2022 10 19 Ad Biomarkers 400
Kromek detectors installed in SPECT/CT systems
By AuntMinnieEurope.com staff writers
Radiation detection technology firm Kromek announced that its digital detectors will be used in Spectrum Dynamics Medical's new digital SPECT/CT scanners.
October 20, 2022
2018 12 11 00 02 7009 Atom Nuclear Lab 400
Siemens scores access to PET data in deal with Blue Earth
By AuntMinnieEurope.com staff writers
Siemens Healthineers has inked a data-sharing deal with Blue Earth Diagnostics for access to anonymized radiohybrid prostate-specific membrane antigen (PSMA) F-18 rhPSMA-7.3 clinical data and images.
October 20, 2022
2019 04 17 20 48 2514 Prostate 3 D 400
EANM highlights consensus document on dementia
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) is participating in a European intersocietal consensus project that will describe the use of biomarkers of neurocognitive disorders in mild cognitive impairment and stages of mild dementia.
October 17, 2022
2019 12 09 23 14 2273 Brain Dementia Leaves 400
GE unveils PET/CT system at EANM congress in Barcelona
By Philip Ward
GE Healthcare has launched the Omni PET/CT platform and Omni Legend system at the annual meeting of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain.
October 16, 2022
2022 10 17 16 27 0747 2022 10 17 Omni Legend Clinical Ge Healthcare 400
First patient imaged in Sofie's FAPI-PET trial
By AuntMinnieEurope.com staff writers
Sofie Biosciences has performed imaging on the first patient in a phase II clinical trial to test the use of its gallium-68 fibroblast activation protein inhibitor (FAPI) PET radiotracer in patients with pancreatic cancer.
October 16, 2022
2018 03 06 00 04 4002 Pancreas New 400
PET/CT scans predict low thyroid function in radiotherapy patients
By Will Morton
Early post-treatment PET/CT scans in patients undergoing radiotherapy for head and neck cancer may predict whether they later develop hypothyroidism, according to a study published on 10 October in Cancer Imaging.
October 13, 2022
2022 10 13 22 01 8325 2022 10 14 Hypothyroidism 400
Week in Review: The power and potential of PET/CT | Imaging of non-small cell lung cancer | News roundup from JFR 2022
By Philip Ward
October 12, 2022
AuntMinnieEurope.com Molecular Imaging Insider
By Philip Ward
October 11, 2022
PET/CT proves value in highlighting musculoskeletal involvement
By Philip Ward
PET/CT is developing an important clinical role in the diagnosis and follow-up of patients with musculoskeletal involvement from hematological and oncological diseases, Spanish researchers have reported.
October 11, 2022
2022 10 12 13 36 9395 2022 10 12 Mol Insider Figure 1 400
PET/CT radiomics model detects primary prostate cancer
By Will Morton
A PET/CT radiomics model based on imaging with a gallium-68 (Ga-68) PSMA-11 radiotracer could help clinicians diagnose primary prostate cancer, according to a study by Chinese researchers published September 30 in EJNMMI Research.
October 11, 2022
2020 07 15 23 29 3710 Cancer Cells Prostate 400
Attention shifts to PET/CT use in cases of non-small cell lung cancer
By Philip Ward
A multinational team of researchers has taken steps to boost radiologists' understanding of how best to use PET/CT and optimize techniques in patients with non-small cell lung cancer.
October 11, 2022
2022 10 11 21 49 4449 2022 10 12 Pet Ct Of Non Small Cell Lung Cancer 400
Previous Page
Page 25 of 124
Next Page